The expansion of the Seeley G. Mudd Library into a hybrid laboratory-library resource will help Northwestern University grow and advance its research mission while providing new opportunities for students to engage with each other and with scientific research. read more >
The new building provides generic, flexible labs with the capabilities necessary to support research as it evolves.read more >
A week-long celebration of art, architecture, and science marked the grand opening of Building Cure in downtown Seattle.read more >
Together, the new buildings bolster important computational research capabilities and advance control systems cybersecurity.read more >
It's an audacious mission — a quest to radically change the course of medicine. Celgene Seattle is aligning their investments in scientific research, manufacturing and most of all, people — to change the way cancer and other serious diseases are treated. read more >
Built around the needs of the patient, the UF Health Heart & Vascular Hospital and UF Health Neuromedicine Hospital is designed with safety and efficiency in mind. Patients have streamlined access to highly specialized, comprehensive outpatient treatment options and inpatient services in one location. read more >
Aspiring to elevate patient health and well-being through family engagement and team-based care, UF Health is leading the fight with compassion, state-of-the-art diagnostic tools, and ever-advancing surgical and non-surgical techniques.
A world-class, modern workplace that fosters innovation and discovery, bringing clinicians together for research, clinical, educational, and community engagement endeavors.
A breakthrough workplace for breakthrough science, Nektar's expanded headquarters gives researchers a collaborative, inspirational, and restorative environment in which to develop innovative medicines.
Born during Juno's rapid expansion into a fully integrated biopharmaceutical company, this project is designed to give researchers connected, interdisciplinary space to revolutionize medicine through cellular immunotherapies.